Загрузка...
Tumor immunity times out: TIM-3 and HMGB1
The characteristics of the tumor microenvironment vary widely. New work shows that after tumor-associated expression of the receptor TIM-3 by dendritic cells, TIM-3 inhibits the antitumor efficacy of DNA vaccines and chemotherapy by binding to the damage-associated molecular pattern molecule, HMGB1.
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672065/ https://ncbi.nlm.nih.gov/pubmed/22910384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ni.2396 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|